Feuille James sold $5.4M of CHYM (indirect holdings)

Feuille James sold 160,100 indirectly-held shares of Chime Financial, Inc. (CHYM) at an average of $33.83 ($33.43–$34.36, $5.42M total) across 4 trades over 2026-11-13 to 2026-11-17.

Original reporting
SEC EDGAR · Feuille James
Published Nov 17, 2026, 11:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 17, 2026, 11:16 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CHYM
Neutral
medium confidence
Mentioned
$CHYM
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CHYMNeutralLow
01

Why it matters

This provides a fresh datapoint on insider behavior and potential sentiment, but it does not disclose any new operational, financial, or strategic change for Chime.

02

Market read

Traders may briefly reassess CHYM sentiment due to director selling, but the event is unlikely to drive a sustained repricing without additional catalysts.

03

What to watch

The transactions are indirect and the filing states no pre-arranged 10b5-1 plan, which can increase interpretive noise; traders should watch for subsequent filings and total insider activity rather than one sale.

Relevance 6/10Novelty 6/10Timing: filed 2026-11-17, covering sales executed 2026-11-13 to 2026-11-17

Background

The article is an SEC Form 4 insider transaction disclosure for Chime Financial, Inc. (CHYM) by director Feuille James, with sales executed over four trades.

Company-level read

Ticker impact

$CHYMNeutralMedium confidence
Context

Chime Financial director Feuille James sold about $5.42M of CHYM shares via open-market transactions dated 2026-11-13 to 2026-11-17, indirect holdings.

Expected impact

Likely limited near-term impact, with traders treating it as routine insider activity unless follow-on selling or other catalysts emerge.

Evidence & confidence

The filing is a Form 4 insider sale with disclosed trade dates and value, but it does not include new company performance, guidance, or regulatory/transactional developments.

Market effects

Minimal, as this is single-company insider selling with no sector-wide signal.

None indicated.

None indicated.

Counterpoint

The sale may be driven by diversification, taxes, or pre-existing personal liquidity needs, so it may not reflect bearish views on CHYM fundamentals.

Key entities

  • Chime Financial, Inc.

    US-listed company whose shares were sold by a director via Form 4.

  • Feuille James

    Director who sold CHYM shares; transactions were open-market sales and indirect holdings.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CHYMHigh

Why is Chime Financial stock climbing today?

Chime Financial (CHYM) stock rose 2.8% in pre-market trading ahead of its inclusion in the S&P MidCap 400 index. Analysts raised price targets, with an average recommendation of 'Buy'. Q3 revenue grew 32% to $718M, and guidance was increased. The stock's gain contrasts with broader market declines.

$CHYMMed

Wells Fargo raises Chime Financial price target on strong results

Wells Fargo raised its price target for Chime Financial (CHYM) to $42.00 from $39.00, citing strong Q3 results and improved 2026 guidance. The company's revenue grew 26% with an 89% gross profit margin, though it remains unprofitable with an EPS of -$0.05. Chime's stock has gained 56% over the past year, trading at $29.87 with a market cap of $11.31 billion. The firm expects the Stride acquisition to close in early 2027, generating $100 million in annual synergies.

$CHYMHighAI 8/10

B.Riley raises Chime Financial stock price target on strong results

B.Riley raised its price target on Chime Financial (NASDAQ:CHYM) to $45.00, citing strong Q3 2026 results. Revenue was $718M, adjusted EBITDA $137M, both exceeding estimates. The company reported GAAP profitability for the third straight quarter, with net income of $44M. Active members reached 10.9M, and management raised full-year guidance. CHYM stock is up 56% over the past year, trading at $29.87.